Arrowhead Pharmaceuticals, Inc. (ARWR)
74.91
-2.23
(-2.89%)
USD |
NASDAQ |
May 21, 12:26
Arrowhead Pharmaceuticals EPS Diluted (Quarterly) : -0.932 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Biogen, Inc. | 2.153 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -137.57M |
| Revenue (Quarterly) | 73.74M |
| Total Expenses (Quarterly) | 206.47M |
| Enterprise Value | 10.44B |
| Gross Profit Margin (Quarterly) | 91.36% |
| Profit Margin (Quarterly) | -186.6% |
| Earnings Yield | -2.87% |
| Normalized Earnings Yield | -2.868 |